Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS

Clinical trial NCT04482712 · WITHDRAWN

Trial details

NCT number: NCT04482712
Sponsor: The University of Texas Health Science Center at San Antonio
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Respiratory Failure Sars-CoV2

Start date: 2021-04-01
Primary completion: 2022-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.